The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metformin Drugs Market Research Report 2025
Synopsis
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.
The global Metformin Drugs market was valued at US$ 3784 million in 2023 and is anticipated to reach US$ 2519.3 million by 2030, witnessing a CAGR of -5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metformin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Drugs.
Report Scope
The Metformin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metformin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metformin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Apotex
Viatris
Mallinckrodt
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol-Myers Squibb
Segment by Type
50 Tablets
100 Tablets
Other
Segment by Application
Hospital
Drugs Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metformin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.
The global Metformin Drugs market was valued at US$ 3784 million in 2023 and is anticipated to reach US$ 2519.3 million by 2030, witnessing a CAGR of -5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metformin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Drugs.
Report Scope
The Metformin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metformin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metformin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Apotex
Viatris
Mallinckrodt
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol-Myers Squibb
Segment by Type
50 Tablets
100 Tablets
Other
Segment by Application
Hospital
Drugs Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metformin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Metformin Drugs Market Overview
1.1 Product Overview and Scope of Metformin Drugs
1.2 Metformin Drugs Segment by Type
1.2.1 Global Metformin Drugs Market Value Comparison by Type (2024-2030)
1.2.2 50 Tablets
1.2.3 100 Tablets
1.2.4 Other
1.3 Metformin Drugs Segment by Application
1.3.1 Global Metformin Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Metformin Drugs Market Size Estimates and Forecasts
1.4.1 Global Metformin Drugs Revenue 2019-2030
1.4.2 Global Metformin Drugs Sales 2019-2030
1.4.3 Global Metformin Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Metformin Drugs Market Competition by Manufacturers
2.1 Global Metformin Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Metformin Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Metformin Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Metformin Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metformin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metformin Drugs, Product Type & Application
2.7 Metformin Drugs Market Competitive Situation and Trends
2.7.1 Metformin Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metformin Drugs Players Market Share by Revenue
2.7.3 Global Metformin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metformin Drugs Retrospective Market Scenario by Region
3.1 Global Metformin Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Metformin Drugs Global Metformin Drugs Sales by Region: 2019-2030
3.2.1 Global Metformin Drugs Sales by Region: 2019-2024
3.2.2 Global Metformin Drugs Sales by Region: 2025-2030
3.3 Global Metformin Drugs Global Metformin Drugs Revenue by Region: 2019-2030
3.3.1 Global Metformin Drugs Revenue by Region: 2019-2024
3.3.2 Global Metformin Drugs Revenue by Region: 2025-2030
3.4 North America Metformin Drugs Market Facts & Figures by Country
3.4.1 North America Metformin Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Metformin Drugs Sales by Country (2019-2030)
3.4.3 North America Metformin Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metformin Drugs Market Facts & Figures by Country
3.5.1 Europe Metformin Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Metformin Drugs Sales by Country (2019-2030)
3.5.3 Europe Metformin Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metformin Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Metformin Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Metformin Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Metformin Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metformin Drugs Market Facts & Figures by Country
3.7.1 Latin America Metformin Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Metformin Drugs Sales by Country (2019-2030)
3.7.3 Latin America Metformin Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metformin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Metformin Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Metformin Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Metformin Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metformin Drugs Sales by Type (2019-2030)
4.1.1 Global Metformin Drugs Sales by Type (2019-2024)
4.1.2 Global Metformin Drugs Sales by Type (2025-2030)
4.1.3 Global Metformin Drugs Sales Market Share by Type (2019-2030)
4.2 Global Metformin Drugs Revenue by Type (2019-2030)
4.2.1 Global Metformin Drugs Revenue by Type (2019-2024)
4.2.2 Global Metformin Drugs Revenue by Type (2025-2030)
4.2.3 Global Metformin Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Metformin Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Metformin Drugs Sales by Application (2019-2030)
5.1.1 Global Metformin Drugs Sales by Application (2019-2024)
5.1.2 Global Metformin Drugs Sales by Application (2025-2030)
5.1.3 Global Metformin Drugs Sales Market Share by Application (2019-2030)
5.2 Global Metformin Drugs Revenue by Application (2019-2030)
5.2.1 Global Metformin Drugs Revenue by Application (2019-2024)
5.2.2 Global Metformin Drugs Revenue by Application (2025-2030)
5.2.3 Global Metformin Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Metformin Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Metformin Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Apotex Metformin Drugs Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Corporation Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Viatris Metformin Drugs Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Corporation Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mallinckrodt Metformin Drugs Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Teva Pharmaceuticals
6.5.1 Teva Pharmaceuticals Corporation Information
6.5.2 Teva Pharmaceuticals Description and Business Overview
6.5.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceuticals Metformin Drugs Product Portfolio
6.5.5 Teva Pharmaceuticals Recent Developments/Updates
6.6 Alkem
6.6.1 Alkem Corporation Information
6.6.2 Alkem Description and Business Overview
6.6.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alkem Metformin Drugs Product Portfolio
6.6.5 Alkem Recent Developments/Updates
6.7 Dr. Reddy’s Laboratories
6.6.1 Dr. Reddy’s Laboratories Corporation Information
6.6.2 Dr. Reddy’s Laboratories Description and Business Overview
6.6.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio
6.7.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.8 Atlas Pharmaceuticals
6.8.1 Atlas Pharmaceuticals Corporation Information
6.8.2 Atlas Pharmaceuticals Description and Business Overview
6.8.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Atlas Pharmaceuticals Metformin Drugs Product Portfolio
6.8.5 Atlas Pharmaceuticals Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharmaceutical Industries Metformin Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Corporation Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Torrent Pharmaceuticals Metformin Drugs Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Bristol-Myers Squibb
6.11.1 Bristol-Myers Squibb Corporation Information
6.11.2 Bristol-Myers Squibb Metformin Drugs Description and Business Overview
6.11.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bristol-Myers Squibb Metformin Drugs Product Portfolio
6.11.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metformin Drugs Industry Chain Analysis
7.2 Metformin Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metformin Drugs Production Mode & Process
7.4 Metformin Drugs Sales and Marketing
7.4.1 Metformin Drugs Sales Channels
7.4.2 Metformin Drugs Distributors
7.5 Metformin Drugs Customers
8 Metformin Drugs Market Dynamics
8.1 Metformin Drugs Industry Trends
8.2 Metformin Drugs Market Drivers
8.3 Metformin Drugs Market Challenges
8.4 Metformin Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Metformin Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Metformin Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Metformin Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Metformin Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Metformin Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Metformin Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Metformin Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Metformin Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Metformin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metformin Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metformin Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Metformin Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metformin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metformin Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Metformin Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Metformin Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Metformin Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Metformin Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Metformin Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Metformin Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Metformin Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Metformin Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Metformin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Metformin Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Metformin Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Metformin Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Metformin Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Metformin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Metformin Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Metformin Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Metformin Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Metformin Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Metformin Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Metformin Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Metformin Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Metformin Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Metformin Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metformin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Metformin Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Metformin Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Metformin Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Metformin Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Metformin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Metformin Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Metformin Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Metformin Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Metformin Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Metformin Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Metformin Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Metformin Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Metformin Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Metformin Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Metformin Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Metformin Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Metformin Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Metformin Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Metformin Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Metformin Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Metformin Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Metformin Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Metformin Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Metformin Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Metformin Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Metformin Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Metformin Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Metformin Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Metformin Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Metformin Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Apotex Corporation Information
Table 76. Apotex Description and Business Overview
Table 77. Apotex Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Apotex Metformin Drugs Product
Table 79. Apotex Recent Developments/Updates
Table 80. Viatris Corporation Information
Table 81. Viatris Description and Business Overview
Table 82. Viatris Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Viatris Metformin Drugs Product
Table 84. Viatris Recent Developments/Updates
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Mallinckrodt Metformin Drugs Product
Table 89. Mallinckrodt Recent Developments/Updates
Table 90. Teva Pharmaceuticals Corporation Information
Table 91. Teva Pharmaceuticals Description and Business Overview
Table 92. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceuticals Metformin Drugs Product
Table 94. Teva Pharmaceuticals Recent Developments/Updates
Table 95. Alkem Corporation Information
Table 96. Alkem Description and Business Overview
Table 97. Alkem Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Alkem Metformin Drugs Product
Table 99. Alkem Recent Developments/Updates
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Business Overview
Table 102. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Dr. Reddy’s Laboratories Metformin Drugs Product
Table 104. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 105. Atlas Pharmaceuticals Corporation Information
Table 106. Atlas Pharmaceuticals Description and Business Overview
Table 107. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Atlas Pharmaceuticals Metformin Drugs Product
Table 109. Atlas Pharmaceuticals Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Corporation Information
Table 111. Sun Pharmaceutical Industries Description and Business Overview
Table 112. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Sun Pharmaceutical Industries Metformin Drugs Product
Table 114. Sun Pharmaceutical Industries Recent Developments/Updates
Table 115. Torrent Pharmaceuticals Corporation Information
Table 116. Torrent Pharmaceuticals Description and Business Overview
Table 117. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Torrent Pharmaceuticals Metformin Drugs Product
Table 119. Torrent Pharmaceuticals Recent Developments/Updates
Table 120. Bristol-Myers Squibb Corporation Information
Table 121. Bristol-Myers Squibb Description and Business Overview
Table 122. Bristol-Myers Squibb Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Bristol-Myers Squibb Metformin Drugs Product
Table 124. Bristol-Myers Squibb Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Metformin Drugs Distributors List
Table 128. Metformin Drugs Customers List
Table 129. Metformin Drugs Market Trends
Table 130. Metformin Drugs Market Drivers
Table 131. Metformin Drugs Market Challenges
Table 132. Metformin Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metformin Drugs
Figure 2. Global Metformin Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Metformin Drugs Market Share by Type in 2023 & 2030
Figure 4. 50 Tablets Product Picture
Figure 5. 100 Tablets Product Picture
Figure 6. Other Product Picture
Figure 7. Global Metformin Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Metformin Drugs Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Drugs Stores
Figure 11. Global Metformin Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Metformin Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Metformin Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Metformin Drugs Average Price (USD/Unit) & (2019-2030)
Figure 15. Metformin Drugs Report Years Considered
Figure 16. Metformin Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Metformin Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Metformin Drugs Players: Market Share by Revenue in 2023
Figure 19. Metformin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Metformin Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Metformin Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Metformin Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Metformin Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Metformin Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Metformin Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Metformin Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Metformin Drugs Sales Market Share by Country (2019-2030)
Figure 44. Latin America Metformin Drugs Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Metformin Drugs Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Metformin Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Metformin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Metformin Drugs by Type (2019-2030)
Figure 54. Global Revenue Market Share of Metformin Drugs by Type (2019-2030)
Figure 55. Global Metformin Drugs Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Metformin Drugs by Application (2019-2030)
Figure 57. Global Revenue Market Share of Metformin Drugs by Application (2019-2030)
Figure 58. Global Metformin Drugs Price (USD/Unit) by Application (2019-2030)
Figure 59. Metformin Drugs Value Chain
Figure 60. Metformin Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
